Preliminary Results of a Screening Programme for Chlamydia in an Asymptomatic Young Population in Spain by Yuguero Torres, Oriol et al.
ORIGINAL RESEARCH
published: 22 February 2021
doi: 10.3389/fpubh.2021.615110






University of London, United Kingdom
Aruni Wilson,





This article was submitted to
Infectious Diseases - Surveillance,
Prevention and Treatment,
a section of the journal
Frontiers in Public Health
Received: 08 October 2020
Accepted: 22 January 2021
Published: 22 February 2021
Citation:
Yuguero O,
Fernández-Armenteros JM, Vilela Á,
Aramburu J, Laín R and Godoy P
(2021) Preliminary Results of a
Screening Programme for Chlamydia
in an Asymptomatic Young Population
in Spain.
Front. Public Health 9:615110.
doi: 10.3389/fpubh.2021.615110
Preliminary Results of a Screening
Programme for Chlamydia in an
Asymptomatic Young Population in
Spain
Oriol Yuguero 1,2*, Jose Manuel Fernández-Armenteros 3, Álvaro Vilela 1,4,
Jesús Aramburu 2,5, Raquel Laín 1 and Pere Godoy 1,2,6,7
1 Institut de Recerca Biomédica de Lleida Fundació Dr. Pifarré (IRBLleida), Lleida, Spain, 2 Facultat de Medicina, Universitat
de Lleida, Lleida, Spain, 3 Secció de Dermatologia, Hospital Universitari, Lleida, Spain, 4Cap Onze de Setembre, Institut
Català de la Salut, Lleida, Spain, 5 Secció Microbiologia, Laboratori Clínic, Hospital Universitari Arnau de VIlanova (HUAV),
Lleida, Spain, 6 Agència de Salut Pública de Catalunya, Lleida, Spain, 7Centro Investigación Biomédica en Red (CIBER) de
Epidemiología y Salud Pública, Epidemiology and Public Health Networking Biomedical Research Centre (CIBERESP),
Madrid, Spain
Introduction: Chlamydia trachomatis (CT) infection has increased in recent years,
reaching 127 million cases in 2016. Possible complications, especially among women,
require intervention for early detection of the infection. The objective of our study
was to determine the prevalence of CT infection in a young, sexually active,
asymptomatic population.
Methods: A cross-sectional study was conducted between December 2017 and 31
December 2018 among young patients aged 18–25 years attending the emergency
room for any reason. The presence of CT and other STIs in urine was determined
by the Allplex Nucleic Acid Amplification Test (NAAT) with a urine sample. All patients
testing positive were followed by the STD unit and tests on all sexual partners/contacts
were offered. Moreover, we obtained data about sexual habits and risk factors via a
self-reporting questionnaire.
Results: One thousand three hundred eight patients were eligible for inclusion of whom
298 consented to participate. Of these, 22/298 (7.4%) were diagnosed with CT. Young
people with two or more sexual partners in the last month and those suffering from
infection by ureaplasma were at greater risk of infection by CT. Up to 50% of participants
do not use barrier methods.
Conclusion: The prevalence of infection by CT in the asymptomatic young population
is higher than expected according to the recent literature in Spain. The scarce use of
barrier methods among this population may be one of the causes of this increase and
one of the targets to work on in order to reduce the prevalence of the infection.
Keywords: sexually transmitted infections, Chlamydia trachomatis, screening, prevention, emergencies and
health services
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KEY POINTS
- The prevalence of infection by CT in the asymptomatic young
population is higher than expected.
- Barrier methods are used in <60% of sexual relations.
- Emergency services can be a good place to implement
screening programmes among young people.
INTRODUCTION
The natural history of CT infection has been studied by many
researchers (1) but with some study design difficulties due to
patient characteristics (2). In 70% of women and 50% of men the
infection can be asymptomatic (3). If left untreated, it can persist
for months and can cause important long-term sequelae. Genital
infection in women can result in pelvic inflammatory disease
(PID), which involves a risk of infertility or ectopic pregnancy,
notwithstanding complications in pregnancy and postpartum. It
can also cause infertility in the male population (4).
According to estimates by the WHO (5), there are at least
127 million CT STI cases worldwide each year (6). In countries
with higher gross domestic product, CT infection is the most
common STI among young heterosexuals (7, 8). In 2017, Unemo
et al. (9) stated that CT infection was the most common bacterial
STI and that it causes reproductive complications, especially in
women (10). The same review recommends the performance
of opportunistic screening in asymptomatic patients or in
patients with risk factors for infection. However, the study by
Hocking (11) did not reveal the expected results in a population
screening programme.
Due to the lack of scientific evidence on what are the
best initiatives to control CT infection, the WHO strategy
on STIs 2016–2021 (12) recommended investigating the cost
effectiveness of screening projects (13). Some countries such
as Australia, the United States and Canada have conducted
screening programmes (14). The number of projects in Europe
has increased in recent years (15), from the first in Norway (16)
to others like those in the UK.
Despite the experience of the various programmes, screening
in asymptomatic patients is not recommended (9). To date,
screening in asymptomatic patients has not proved very cost
effective. For example, in the United Kingdom, various screening
projects have been conducted comparing the results between
asymptomatic patients and other risk groups, without yielding
very encouraging results (17).
Other screening programmes have been conducted in
asymptomatic patients such as the one carried out in Bangkok
in a homosexual population (18), and in Paris (19) on patients
attending a specific STI center, where the prevalence was 5.7%.
In Catalonia, according to data from the CEEISAT (20), there
has been an increase from 55 cases per 100,000 people in 2016
to 139,90 cases in 2019. A pilot study conducted in our hospital
(Lleida, Spain) in 2013 with patients attending for a sexually
transmitted infection (STI) yielded a prevalence of infection by
CT of 10%, which was higher than expected (21).
The involvement of the Emergency Services in the control of
CT infection has been discussed in other initiatives. Currently
in Spain, rapid detection tests for CT such as those described
by Gaydos et al. (22) are not used. In other countries tests
with self-collected samples have been used successfully (23).
In 2018, Adamson and Klausner presented the results of the
screening programme for CT infection in Australia (24) where
emergency services were involved. The aim of our study was to
detect the prevalence of CT infection in asymptomatic, sexually
active young patients attending the emergency room for reasons
unrelated to an STI.
METHODOLOGY
An epidemiological cross-sectional study was conducted on the
prevalence of CT infection detected in a screening programme
for patients who attended the emergency room between 1
December 2017 and 31 December 2018. The Emergency
Department of the Arnau de Vilanova University Hospital
receives close to 90,000 patients per year of whom about 7,000
are between 18 and 25 years old.
Variables
All patients were interviewed with questions based on
the CEEISCAT epidemiological survey (25). Subjects’
sociodemographic variables (age, sex, country of origin,
level of education, and employment status) and epidemiological
variables (sexual orientation, number of sexual partners in the
last month and year, use of barrier methods and the practice of
prostitution), and medical history (previous diagnosis of STIs in
the last year and pregnancy) were evaluated. In addition to the
detection of CT infection, the same sample was used to detect
Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma
genitalium, Mycoplasma hominis, Trichomonas vaginalis, and
Neisseria gonorrhoeae.
The method applied for the diagnosis of CT infection
and other STIs was the AllplexTM Seegene R© Nucleic Acid
Amplification Test (NAAT) STI Essential Assay, in urine for men
and women, with 88–95% sensitivity and 95–98% specificity (26)
to detect CT infection. This test is recommended by the Catalan
Health Department. A urethral sample is regarded as the gold
standard specimen type but, due to the nature of this study using
asymptomatic emergency room recruitment for practical and
acceptability purposes, a urine sample was collected for diagnosis.
The urine samples were sent to the laboratory, stored in the
refrigerator at between 4 and 8◦C until analyzed within 48 h.
The samples were prepared as indicated by the manufacturer
(Seegene). DNA from the samples was extracted with EZ1 or
QIASymphony (QIAGEN R©) equipment. PCR detection of C.
trachomatis and other microorganisms was performed with the
AllplexTM STI-7 V1-1 kit (Seegene R©).
The amplification cycle threshold was determined by the
CFX96 software using values recommended by the Seegene
Allplex testing kit. A valid result required that the sample entered
exponential growth with a sigmoid-shaped curve in order to cross
the cycle threshold.
In addition, an internal quality control was carried out on
the procedure, which if not passed, invalidates the result. Then,
extraction must be done again and started again. If the internal
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control is failed again, it is excluded. In our study there were two
samples that need to be repeated, but were finally validated.
Every week, the research team reviewed the participants’
results for that period. If the result was negative, no
communication was issued to the patient. However, the
researchers did inform the patient’s Primary care doctor.
Patients with CT positive or result for another STI were
referred to the STI Unit at the Arnau de Vilanova University
Hospital, Lleida (Spain) where they were administered treatment
for the infection, they performed the contact study, and all
patients and their sexual contacts had the opportunity to undergo
serological tests to detect other sexually transmitted diseases
(HIV, Hepatitis B and C and Syphilis).
Inclusion Criteria
Sexually active patients between 18 and 25 years of age attending
the Emergency Room between the dates set out above for reasons
not related to a sexually transmitted infection were offered to
participate consecutively recruiting 24 h a day, 7 days a week.
A person was deemed sexually active if they had had sex in the
previous 6 months.
Exclusion Criteria
Patients who did not agree to participate or who had symptoms
that could be caused by CT were excluded.
Sample Size
In reference to sample size (27), accepting an alpha risk of 0.05
(i.e., 95% confidence) and a beta risk of 0.2 (i.e., a statistical
power of 80%) in a two-sided test, a sample size of 1,031 patients
is needed to identify a difference ≥0.02% from the expected
prevalence of 0.05 described previously (28). No drop-outs
are anticipated.
Statistical Analysis
Qualitative variables were described by absolute frequencies and
percentages. For quantitative variables, the median and 25 and
75% percentiles were obtained. The prevalence of CT infection
and other STIs were estimated and the 95% confidence interval
(CI) was calculated. Whenever application assumptions were
held, the Pearson’s Chi-square test was used to compare the
qualitative variables, and the Mann-Whitney test was used for
the quantitative variables. The crude odds ratios (OR) calculated
by the Wald method and their 95% CI calculated using normal
approximation were also obtained.
A logistic regression model was developed to determine the
variables associated with CT infection. The forward selection
approach based on the likelihood ratio test was followed
to determine the independent variables of the multivariable
analysis. Age and sex were included as adjustment variables.
Calibration was evaluated using the Hosmer-Lemeshow test, and
discrimination with the area under the ROC curve. The adjusted
OR are presented, along with the 95% CI. In all analyses an alpha
error of 5% was assumed and the R statistical program was used.
FIGURE 1 | Flowchart of patient inclusion.
RESULTS
During the study period, 7,267 patients aged between 18
and 25 years attended the emergency room. Of these, 3,775
(51.9%) attended with symptoms that could be caused by an
infection by CT (abdominal pain, dysuria or genital secretion).
Two thousand one hundred eighty-two patients denied being
sexually active (30%). Of the 1,308 patients who were eligible
to participate in the study, 298 (22.9%) agreed to participate
(Figure 1).
54.4% were women and the median age was 22 years. The
sociodemographic variables are presented in Table 1. Ninety-
three percent of participants reported themselves as being
heterosexual, 4.4% bisexual, and the remaining 2.3% homosexual.
Just over one-tenth (10.4%) had had two or more partners in the
last month, 49.3% had not used a condom in their last sexual
intercourse, and 4.4% reported a previous STI (Table 2).
In the screening study, 22 CT-infected patients were detected
(7.4%, 95% CI = 4.8–11.1%).
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Mean age (P25–P75) 22 [20–23.08]
Employment
Craftspeople and skilled workers in the manufacturing
and construction industries (except operators of plant
and machinery)
23 (7.72%)
Accounting, administrative, and other office employees 12 (4.03%)
Student 154 (51.7%)
Elementary occupations 8 (2.68%)
Other technical, scientific, and intellectual professionals 7 (2.35%)
Unemployed 30 (10.1%)
Technical, scientific, and intellectual professionals 16 (5.37%)
Qualified agricultural, livestock, forestry, and fisheries
employees
25 (8.39%)











South America 30 (10.1%)
Education level
No education 6 (2.01%)
Primary 19 (6.38%)
Vocational training 76 (25.5%)
Secondary 82 (27.5%)
University 115 (38.6%)
Description of the sample included in the study.
An STI was diagnosed in 34 patients (11.4%). In addition to
the 22 infected with CT, 11 were infected with U. urealyticum
(3.7%), 2 with M. genitalium (0.6%), 1 with T. vaginalis (0.3%),
and 1 with N. gonorrhoeae (0.3%). Three patients were co-
infected with CT and Ureaplasma. Only in three patients was
serologic screening carried out for hepatitis B, C, syphilis, and
HIV. HIV was detected in one of these cases.
CT infection showed no association with age or gender,
but manual workers (17.4%), service workers (17.4%), and the
unemployed (13.3%) had a higher prevalence of infection than
students (3.9%). Patients with secondary school studies also had
a higher prevalence of CT than the other groups (Table 3).
Approximately 40% of the study participants did not use barrier
methods routinely (Table 4).
Twenty-one patients with CT received treatment (95.5%).
The one patient who did not receive treatment was due to
not attending the Unit or visiting their primary care physician.
Focusing on the other STIs, only four patients were treated for
Ureaplasma and one for Neisseria. Twelve of the patients with











Number of partners in the last month
0–1 267 (89.6%)
2+ 31 (10.4%)







Routine use of Barrier methods
No 124 (41.6%)
Yes 174 (58.4%)









Within the last year
No 297 (99.7%)
Yes 1 (0.34%)
Clinical and epidemiological characteristics of the patients participating in the study.
CT identified their contact (54.5%) in the last month. None of the
patients reported more than one contact. Nine were diagnosed
with and treated for CT. The total number of patients infected
with CT was 31.
Logistic regression analysis showed that patients who had
had two or more partners in the last month [OR 3.8; 95% CI
(1.2–12.1)] and were infected with Ureaplasma [OR 6.8; 95% CI
(1.6–29.2)] had a higher risk of CT infection.
DISCUSSION
The prevalence of Chlamydia trachomatis infection in young
asymptomatic patients is 7.4% in the screened patients.
This figure is higher than that previously described in our
environment, since prevalence had been estimated at 5% (29).
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TABLE 3 | Patient demographic variables according to Chlamydia infection.
Yes (N = 22) No (N = 276) P-Value OR (95% CI)
Sex 0.81
Male 9 (40.9%) 127 (46.0%) Ref
Female 13 (59.1%) 149 (54.0%) 1.23 [0.51; 2.97]
Age 0.752
22.0 [21.0; 23.0] 22.0 [20.0; 24.0] 1.03 [0.85; 1.26]
Employment –
Craftspeople and skilled workers in the manufacturing and
construction industries (except operators of plant and machinery)
4 (18.2%) 19 (6.88%)
Accounting, administrative and other office employees 1 (4.55%) 11 (3.99%)
Student 6 (27.3%) 148 (53.6%)
Elementary occupations 0 (0.00%) 8 (2.90%)
Other technical, scientific and intellectual professionals 1 (4.55%) 6 (2.17%)
Unemployed 4 (18.2%) 26 (9.42%)
Technical, scientific and intellectual professionals 2 (9.09%) 14 (5.07%)
Qualified agricultural, livestock, forestry and fisheries employees 0 (0.00%) 25 (9.06%)
Workers in catering, personal, security and sales services 4 (18.2%) 19 (6.88%)
Country of origin –
Spain 17 (77.3%) 197 (71.4%)
Rest of Europe 0 (0.00%) 27 (9.78%)
Africa 2 (9.09%) 23 (8.33%)
Asia 1 (4.55%) 1 (0.36%)
South America 2 (9.09%) 28 (10.1%)
Education level –
No education 1 (4.55%) 5 (1.81%) Ref
Primary 1 (4.55%) 18 (6.52%) 0.28 [0.01; 5.27]
Vocational training 7 (31.8%) 69 (25.0%) 0.51 [0.05; 4.98]
Secondary 8 (36.4%) 74 (26.8%) 0.54 [0.06; 5.22]
University 5 (22.7%) 110 (39.9%) 0.23 [0.02; 2.33]
Chi square test for sex, and Mann-Whitney test for age. OR obtained univariate logistic regression.
In 2010 a similar study was conducted in Spain that showed a
prevalence of 4% (30).
This is the first screening study for infection by CT in young
asymptomatic subjects in Catalonia, Spain. The study results
are preliminary, although we have considered that they are
sufficiently important to be communicated. We believe that the
population attending out-of-hours healthcare services was a good
choice since it is difficult to contact young patients as they tend to
visit the emergency room for acute problems or accidents (31).
The mean age of our sample was 22 years and there was
a predominance of women (54.5%). However, there were no
associations with gender, age, sexual orientation or country
of origin.
There was an association with the number of sexual partners
in the last month: the greater the number of sexual partners in the
last month, the higher the risk of CT infection. This was already
described in 1992 by Joffe et al. (32) and recently by Lopez-de-
Munain in a recent study (33) which also revealed a higher risk
of infection in a cohort of patients who attended an STI unit and
reported two or more sexual partners in the last month.
The study allowed us to detect 31 cases of CT in asymptomatic
patients (22 cases via Emergency Room screening and nine
via contact tracing of these positive cases), thus preventing the
spread of the disease and the subsequent complications that
may arise from asymptomatic infection. Also, in the subsequent
study, we detected one case of HIV in an asymptomatic patient.
Probably, if HIV serology had been performed on a larger
number of patients, more cases would have been detected.
It was disappointing that many patients have not undergone
serological tests despite their positive results for other STIs.
However, serologies can be a marker of past exposure rather
than current infection, especially for viral infections like HIV or
HBV, but recent recommendations from Spanish guidelines (34)
recommend testing for HIV in all patients with different STIs to
detect hidden infections.
The co-infection of CT with U. parvum is notable. This
association was also described in other studies. Kim et al.
(35), Ndeikoundam Ngangro et al. (36), and Yamazaki (37)
suggest that the presence of Ureaplasma has a significant effect
on the presence of C. trachomatis in the genital tract. Berçot
et al. (38) go further and relate this co-infection with the
establishment of chronic C. trachomatis infection. We believe
the possibility of using tests that detect various infections in
screening programmes may be in order to achieve greater patient
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TABLE 4 | Epidemiological and clinical variables of patients infected by Chlamydia.
Yes (N = 22) No (N = 276) P-value OR (95% CI)
Sexual orientation –
Heterosexual 22 (100%) 255 (92.4%)
Homosexual 0 (0.00%) 7 (2.54%)
Bisexual 0 (0.00%) 13 (4.71%)
Unknown 0 (0.00%) 1 (0.36%)
Stable partner >0.999
No 9 (40.9%) 108 (39.1%) Ref
Yes 13 (59.1%) 168 (60.9%) 0.93 [0.38–3.25]
Number of partners in the last month 0.064
0–1 17 (77.3%) 250 (90.6%) Ref
2+ 5 (22.7%) 26 (9.42%) 2.83 [0.96–8.29]
Number of partners in the last year 0.326
1 11 (50.0%) 177 (64.1%) Ref
2–5 8 (36.4%) 76 (27.5%) 1.69 [0.66; 4.38]
6+ 3 (13.6%) 23 (8.33%) 2.10 [0.54; 8.08]
Exercising prostitution –
No 22 (100%) 273 (98.9%)
Yes 0 (0.00%) 3 (1.09%)
Routine use of Barrier methods >0.999
No 9 (40.9%) 115 (41.7%) Ref
Yes 13 (59.1%) 161 (58.3%) 1.03 [0.43–2.49]
Condom use at last intercourse 0.465
No 13 (59.1%) 134 (48.6%) Ref
Yes 9 (40.9%) 142 (51.4%) 0.65 [0.27–1.58]
Pregnancy –
No 21 (95.5%) 270 (97.8%)
Yes 1 (4.55%) 6 (2.17%)
Previous STI diagnosis? –
No 20 (90.9%) 265 (96.0%)
Yes 2 (9.09%) 11 (3.99%)
Within the last year –
No 22 (100%) 275 (99.6%)
Yes 0 (0.00%) 1 (0.36%)
P-values correspond to the chi-square test. OR obtained univariate logistic regression.
information, although there is a need to perform cost-benefit
studies and discard overdiagnosis and overtreatment before
recommending their use.
One study (39) showed that even in asymptomatic women
there is a high prevalence of STIs whether they belong to a
high-risk group or not, as our results confirm.
We also believe it is relevant that ∼40% of participants do
not use barrier methods regularly and did not use a condom
upon their last sexual intercourse. This is remarkable given the
multitude of awareness campaigns that exist and the little impact
they have on young people. This situation has been described
previously, specifically in campaigns on STIs (40). Due to their
apparent lack of effectiveness, strategies to promote condom use
and improve their impact on young people should be reviewed.
To date, for reasons of cost-effectiveness, in Spain, screening
programmes for CT had only been conducted in patients with
risk factors, such as patients attending STI clinics (21) or
pregnant women (41). Through an opportunistic case-finding
strategy, the project took advantage of visits by young sexually
active patients to an emergency room to reach one of the main
risk groups which, being asymptomatic, is very unlikely to attend
the physician’s office.
We believe that detecting CT infection in 7.4% of young
people highlights that prevalence could increase in the following
years and justifies planning strategies to detect infection in young
patients since current education and awareness strategies show
little impact. The benefit of receiving treatment and avoiding
complications and sequelae is sufficiently important to consider
implementing a nationwide strategy.
The main limitation of our study is the current sample size.
We have achieved a response from 23% of the participants,
hence the size of our sample is small, and this could lead
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to sample bias. However, the screening programme continues.
Moreover, another limitation is that younger patients are
sometimes accompanied in the emergency room by relatives
in whose presence these patients do not admit to the
practice of sexual relations. Also, the out-of-hours healthcare
services user population may not be representative of all
young people.
Our study provides evidence of the importance of a screening
programme, but also the importance of campaigns to raise
awareness in the use of barrier methods, since the number of
sexual partners is still the main factor conditioning CT infection.
Finally, we think that these results encourage us to continue
with the study and to promote screening programmes among the
general population.
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